Health Trials

Severe Eosinophilic Asthma

2

Review clinical trials related to Severe Eosinophilic Asthma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

This is an observational, multicenter, prospective study on patients with severe eosinophilic asthma treated with benralizumab aimed at evaluating the achievement of partial and complete clinical remission.

Participants needed: 335
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: AstraZenecaUpdated: Jul 8, 2026Locations: 28
Eligibility criteria

Adults (≥ 18 years old) diagnosed with severe uncontrolled eosinophilic asthma. [+3]

Benralizumab treatment within the 12 months prior to study enrollment and up to... [+5]

Read more
Status: Not yet recruiting

Fasenra: An Asthma Study

The goal of this observational study is to learn more about the effectiveness of benralizumab (Fasenra, 30 mg every 8 weeks) in maintaining asthma control in people with severe eosinophilic asthma. Participants will have electronic medication monitors fitted to their usual maintenance inhaler, as well as a study-provided anti-inflammatory rescue inhaler, albuterol-budesonide (AirSupra). These monitors will track when each inhaler is used. Participants will also upload time-stamped photos of their benralizumab administration to their electronic medical records.

Participants needed: 40
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Endeavor HealthUpdated: Jul 7, 2026Locations: 1
Eligibility criteria

Capable of giving signed informed consent, which includes compliance with the re... [+5]

Current smoker (including tobacco, vaping, and marijuana). Former smokers must h... [+7]

Read more